SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001157523-12-001047
Filing Date
2012-02-27
Accepted
2012-02-27 08:34:38
Documents
11
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 10-K a50172459.htm 10-K 1542069
2 EXHIBIT 23.1 a50172459ex23_1.htm EX-23.1 4272
3 EXHIBIT 31.1 a50172459ex31_1.htm EX-31.1 15559
4 EXHIBIT 32.1 a50172459ex32_1.htm EX-32.1 7358
5 GRAPHIC logo.jpg GRAPHIC 2184
  Complete submission text file 0001157523-12-001047.txt   3844194

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT opxa-20111231.xml EX-101.INS 426983
7 XBRL TAXONOMY EXTENSION SCHEMA opxa-20111231.xsd EX-101.SCH 17695
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE opxa-20111231_cal.xml EX-101.CAL 31741
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opxa-20111231_def.xml EX-101.DEF 103925
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE opxa-20111231_lab.xml EX-101.LAB 112390
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opxa-20111231_pre.xml EX-101.PRE 111152
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33004 | Film No.: 12640225
SIC: 2834 Pharmaceutical Preparations